Using MRD to inform allocation of stem cell transplants in ALL and AML
Fabio Guolo, MD, of the University of Genoa, Genoa, Italy, spoke to us at the 23rd Congress of the European Hematology Association (EHA) 2018, held in Stockholm, Sweden, about how measurable residual ...
Author: VJHemOnc
Added: 07/18/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Hematology | Italy Health | Politics | Stem Cell Therapy | Stem Cells | Sweden Health | Transplants